Picture BIO.NRW Greener Manufacutring Show 2023 Köln 650x100px

Document › Details

TxCell S.A.. (1/25/17). "Press Release: Txcell Launches a Capital Increase of around 11 Million Euros with Shareholders’ Preferential Subscription Rights [Not for release directly or indirectly in the United States of America, Canada, Australia or Japan]

	Organisation	TxCell S.A. (Euronext Paris: TXCL)
	Organisation 2	Bpifrance
	Group	France (govt)
	Product	investment banking
	Product 2	cell therapy
	Index term	TxCell–SEVERAL: investment, 201701–201702 capital increase €11.1m with 5.55m new shares with warrants at unit price of €2
	Person	Boissel, Stéphane (SparingVision 202010– CEO before Sangamo + TxCell + Genclis + Transgene + Innate Pharma + Lazard)

Original Document
accessed by [iito] on 2017-02-23

Record changed: 2023-06-05

Picture BIO.NRW Greener Manufacutring Show 2023 Köln 650x200px

More documents for TxCell S.A. (Euronext Paris: TXCL)

[1] Sangamo Therapeutics, Inc.. (7/23/18). "Press Release: Sangamo Therapeutics to Acquire TxCell". Richmond, CA & Valbonne....
[2] TxCell S.A.. (7/9/18). "Press Release: TxCell Exercises In-license Option to the University of British Columbia's Intellectual Property Rights of the HLA-A2 CAR-Treg Program". Valbonne....
[3] TxCell S.A.. (6/21/18). "Press Release: First in Vivo Proof-of-Concept Data with CD8+ CAR-Treg Presented at FOCIS 2018". Valbonne....
[4] TxCell S.A.. (5/31/18). "Press Release: TxCell Names Lonza as Its CAR-Treg Cellular Product Manufacturer". Valbonne & Basel....
[5] TxCell S.A.. (4/25/18). "Press Release: TxCell – Financial Information for the 1st Quarter of 2018 and Availability of the 2017 Registration Document (document de référence)". Valbonne....
[6] TxCell S.A.. (1/17/18). "Press Release: TxCell Obtains Government Funding to Advance Its Lead CAR-Treg Program". Valbonne....
[7] TxCell S.A.. (12/18/17). "Press Release: TxCell Completes CAR-Treg Manufacturing Process Development and Provides Update to CMO Selection". Valbonne....
[8] TxCell S.A.. (10/25/17). "Press Release: TxCell Renegotiates OCABSA Financing Option to Extend Cash Runway [Not for distribution in the United States of America, Canada, Australia and Japan]". Valbonne....
[9] TxCell S.A.. (10/19/17). "Press Release: Financial Information for the 3rd Quarter of 2017". Valbonne....
[10] TxCell S.A.. (7/26/17). "Press Release: TxCell – Financial Information for the 2nd Quarter of 2017". Valbonne....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]